April 29, 2015 BONESUPPORT Announces CE-Mark of CERAMENT™|V, the First Injectable Vancomycin Eluting Bone Substitute in the Management of Osteomyelitis
April 23, 2015 RESULTS OF PHASE 1 STUDY OF BETALUTIN™ IN PATIENTS WITH NON-HODGKIN LYMPHOMA TO BE PRESENTED AT THE INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA